(CercleFinance.com) – Syensqo, the specialty chemicals company to be created from the spin-off of Solvay in December, reveals its growth strategy for the next five years ‘aimed at creating significant value’, as well as its medium-term financial objectives term.
On an organic basis, it targets net revenue growth between 5 and 7% over the period 2024-28, as well as, in percentage terms and by 2028, an underlying EBITDA margin around the mid-range. twenties and an ROCE in the mid-twenties.
Achieving these objectives should enable it to generate more than seven billion euros in cash between 2024 and 2028. Syensqo wishes to prioritize growth ‘while maintaining a solid ‘investment grade’ financial rating’.